Ladenburg Thalmann Financial Services’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $122K | Sell |
2,672
-968
| -27% | -$44.2K | ﹤0.01% | 2865 |
|
2019
Q3 | $130K | Buy |
3,640
+231
| +7% | +$8.25K | ﹤0.01% | 2765 |
|
2019
Q2 | $136K | Sell |
3,409
-200
| -6% | -$7.98K | ﹤0.01% | 2747 |
|
2019
Q1 | $150K | Buy |
3,609
+20
| +0.6% | +$831 | ﹤0.01% | 2608 |
|
2018
Q4 | $132K | Buy |
3,589
+78
| +2% | +$2.87K | ﹤0.01% | 2557 |
|
2018
Q3 | $171K | Buy |
3,511
+500
| +17% | +$24.4K | ﹤0.01% | 2433 |
|
2018
Q2 | $126K | Hold |
3,011
| – | – | ﹤0.01% | 2609 |
|
2018
Q1 | $126K | Sell |
3,011
-909
| -23% | -$38K | ﹤0.01% | 2609 |
|
2017
Q4 | $171K | Sell |
3,920
-290
| -7% | -$12.7K | ﹤0.01% | 2325 |
|
2017
Q3 | $179K | Buy |
4,210
+484
| +13% | +$20.6K | ﹤0.01% | 2199 |
|
2017
Q2 | $160K | Buy |
3,726
+1,202
| +48% | +$51.6K | ﹤0.01% | 2184 |
|
2017
Q1 | $106K | Buy |
2,524
+637
| +34% | +$26.8K | ﹤0.01% | 2367 |
|
2016
Q4 | $74K | Sell |
1,887
-1,422
| -43% | -$55.8K | ﹤0.01% | 2551 |
|
2016
Q3 | $147K | Sell |
3,309
-119
| -3% | -$5.29K | ﹤0.01% | 1969 |
|
2016
Q2 | $143K | Buy |
3,428
+144
| +4% | +$6.01K | ﹤0.01% | 1901 |
|
2016
Q1 | $133K | Sell |
3,284
-230
| -7% | -$9.32K | ﹤0.01% | 1880 |
|
2015
Q4 | $180K | Buy |
3,514
+424
| +14% | +$21.7K | ﹤0.01% | 1658 |
|
2015
Q3 | $145K | Buy |
3,090
+232
| +8% | +$10.9K | ﹤0.01% | 1724 |
|
2015
Q2 | $178K | Sell |
2,858
-2,146
| -43% | -$134K | ﹤0.01% | 1691 |
|
2015
Q1 | $309K | Buy |
5,004
+1,218
| +32% | +$75.2K | 0.01% | 1297 |
|
2014
Q4 | $205K | Buy |
3,786
+1,422
| +60% | +$77K | ﹤0.01% | 1415 |
|
2014
Q3 | $125K | Buy |
2,364
+2
| +0.1% | +$106 | ﹤0.01% | 1477 |
|
2014
Q2 | $123K | Hold |
2,362
| – | – | ﹤0.01% | 1468 |
|
2014
Q1 | $111K | Buy |
2,362
+598
| +34% | +$28.1K | ﹤0.01% | 1449 |
|
2013
Q4 | $78K | Buy |
1,764
+8
| +0.5% | +$354 | ﹤0.01% | 1622 |
|
2013
Q3 | $68K | Buy |
1,756
+244
| +16% | +$9.45K | ﹤0.01% | 1619 |
|
2013
Q2 | $53K | Buy |
+1,512
| New | +$53K | ﹤0.01% | 1706 |
|